News & Updates

Nirmatrelvir-ritonavir benefits persist against COVID

07 Nov 2023 by

Management of most adults with COVID-19, particularly those with mild-to-moderate disease, is increasingly occurring in the outpatient setting due to the availability of effective treatment options.

Nirmatrelvir-ritonavir benefits persist against COVID

07 Nov 2023

Depression severity tied to respiratory symptoms

05 Nov 2023

Depression levels among adults appear to be positively associated with respiratory symptoms, asthma, and chronic obstructive pulmonary disease (COPD), according to a study.

Depression severity tied to respiratory symptoms

05 Nov 2023

Higher nasal CPAP helps avoid extubation failure in extremely preterm infants

02 Nov 2023

Extubation with higher levels of nasal continuous positive airway pressure (nCPAP) in preterm infants leads to a lower incidence of extubation failure compared with standard nCPAP levels, without compromising safety, according to a study.

Higher nasal CPAP helps avoid extubation failure in extremely preterm infants

02 Nov 2023

Ritonavir-boosted nirmatrelvir protects older adults against post-COVID conditions

26 Oct 2023 by

Treatment with nirmatrelvir/ritonavir helps lower the incidence of post-COVID conditions (PCC) in older adults, according to a large study.

Ritonavir-boosted nirmatrelvir protects older adults against post-COVID conditions

26 Oct 2023

Older age, comorbidities drivers of hospitalization for RSV

25 Oct 2023 by

Advanced age (≥65 years) and comorbidities increase the risk of respiratory syncytial virus (RSV)-associated hospitalization, according to a presentation at IDWeek 2023.

Older age, comorbidities drivers of hospitalization for RSV

25 Oct 2023

Supranormal FEV1, FVC values linked to better lung function

21 Oct 2023

Nearly 3 percent of the general population demonstrate greater-than-expected values of forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC), which are both indicative of a better lung function, according to a recent study in Austria.

Supranormal FEV1, FVC values linked to better lung function

21 Oct 2023

Face mask use tied to cardiovascular symptoms

20 Oct 2023 by

Use of face masks remains an effective method in preventing COVID-19 transmission, but a recent study in Singapore has found that wearing of face masks is also associated with more self-reported cardiovascular symptoms.

Face mask use tied to cardiovascular symptoms

20 Oct 2023

Beta strain-containing bivalent vaccine protects against various SARS-CoV-2 variants

20 Oct 2023 by

A Beta variant-containing vaccine conferred protection against different SARS-CoV-2 variants, with an acceptable safety profile in adults <60 years, a phase III trial has shown.

Beta strain-containing bivalent vaccine protects against various SARS-CoV-2 variants

20 Oct 2023

First-line therapies for advanced NSCLC improve survival, QoL

16 Oct 2023

Clinical trials on first-line therapies for advanced or metastatic nonsmall cell lung cancer (NSCLC) from 2010 to 2020 have reported better survival and a steady improvement in quality of life (QoL) among patients, according to the results of a systematic review.

First-line therapies for advanced NSCLC improve survival, QoL

16 Oct 2023

RSV vaccine effective across two seasons

16 Oct 2023 by

The respiratory syncytial virus (RSV) vaccine by GSK demonstrated sustained effectiveness of about 67 percent among adults 60 years or older across two full RSV seasons in a phase III study, says an infectious disease expert who reported findings at IDWeek 2023.

RSV vaccine effective across two seasons

16 Oct 2023

News & Updates

Filter by Specialty:

Specialty:

Nirmatrelvir-ritonavir benefits persist against COVID

Nirmatrelvir-ritonavir benefits persist against COVID

Depression severity tied to respiratory symptoms

Depression severity tied to respiratory symptoms

Higher nasal CPAP helps avoid extubation failure in extremely preterm infants

Higher nasal CPAP helps avoid extubation failure in extremely preterm infants

Ritonavir-boosted nirmatrelvir protects older adults against post-COVID conditions

Ritonavir-boosted nirmatrelvir protects older adults against post-COVID conditions

Older age, comorbidities drivers of hospitalization for RSV

Older age, comorbidities drivers of hospitalization for RSV

Supranormal FEV1, FVC values linked to better lung function

Supranormal FEV1, FVC values linked to better lung function

Face mask use tied to cardiovascular symptoms

Face mask use tied to cardiovascular symptoms

Beta strain-containing bivalent vaccine protects against various SARS-CoV-2 variants

Beta strain-containing bivalent vaccine protects against various SARS-CoV-2 variants

First-line therapies for advanced NSCLC improve survival, QoL

First-line therapies for advanced NSCLC improve survival, QoL

RSV vaccine effective across two seasons

RSV vaccine effective across two seasons